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Background: Protein arginine methylation is a post-translational modification involved in important biological
processes such as transcription and RNA processing. This modification is catalyzed by both type I and II protein
arginine methyltransferases (PRMTs). One of the most conserved type I PRMTs is PRMT1, the homolog of which is
Hmt1 in Saccharomyces cerevisiae. Hmt1 has been shown to play a role in various gene expression steps, such as
promoting the dynamics of messenger ribonucleoprotein particle (mRNP) biogenesis, pre-mRNA splicing, and
silencing of chromatin. To determine the full extent of Hmt1’s involvement during gene expression, we carried out
a genome-wide location analysis for Hmt1.
Results: A comprehensive genome-wide binding profile for Hmt1 was obtained by ChIP-chip using NimbleGen
high-resolution tiling microarrays. Of the approximately 1000 Hmt1-binding sites found, the majority fall within or
proximal to an ORF. Different occupancy patterns of Hmt1 across genes with different transcriptional rates were
found. Interestingly, Hmt1 occupancy is found at a number of other genomic features such as tRNA and snoRNA
genes, thereby implicating a regulatory role in the biogenesis of these non-coding RNAs. RNA hybridization analysis
shows that Hmt1 loss-of-function mutants display higher steady-state tRNA abundance relative to the wild-type.
Co-immunoprecipitation studies demonstrate that Hmt1 interacts with the TFIIIB component Bdp1, suggesting a
mechanism for Hmt1 in modulating RNA Pol III transcription to regulate tRNA production.
Conclusions: The genome-wide binding profile of Hmt1 reveals multiple potential new roles for Hmt1 in the
control of eukaryotic gene expression, especially in the realm of non-coding RNAs. The data obtained here will
provide an important blueprint for future mechanistic studies on the described occupancy relationship for genomic
features bound by Hmt1.
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Protein arginine methylation is a post-translational modifi-
cation commonly found in nucleic acid-binding proteins
[reviewed in [1,2]. This modification is catalyzed by a family
of evolutionarily conserved enzymes called protein arginine
methyltransferases (PRMTs). PRMTs can be classified into
four major classes depending on the type of methylarginine
generated by the enzyme. Type I, II, and III PRMTs can all
catalyze monomethylation and generate monomethylargi-
nine (MMA) on a guanidinum nitrogen of arginine residues* Correspondence: mcyu@buffalo.edu
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reproduction in any medium, provided the orin proteins. Type I PRMTs then catalyze the formation of
asymmetric dimethylarginine (ADMA) and type II PRMTs,
symmetric dimethylarginine (SDMA). Type III can only
catalyze monomethylarginine while the Type IV enzyme,
which has only been described in Saccharomyces cerevisiae
[3], catalyzes monomethylation of the delta nitrogen atom
of the arginine residue. Currently, eleven PRMT family
members have been identified in the metazoans, with
PRMT1 (Type I) and PRMT5 (Type II) being the most
conserved members of the PRMT family across the
eukaryotic spectrum reviewed in [4].
Hmt1 (also termed Rmt1) has been identified as the
major type I PRMT in the budding yeast S. cerevisiae and
is the functional homolog of mammalian PRMT1 [5,6]. Al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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knowledge of these substrates’ biological functions has
helped infer Hmt1’s role as a regulator during various
steps in gene expression. These substrates include histones
H2A, H2B, H3, and H4 [7,8], mRNA export factors Npl3
[5] and Yra1 [9], pre-mRNA splicing factors Snp1 [10], 3’-
end processing factors Hrp1 [11] and Nab2 [12], and the
nucleolar proteins Nop1, Nsr1, and Gar1 [13]. Functional
studies have shown that yeast mutants lacking Hmt1 dis-
play compromised intracellular protein trafficking, aberrant
messenger ribonucleoprotein particle (mRNP) formation
and defective silent chromatin formation [9,11,14]. The
defects seen in the silent chromatin formation in Hmt1
loss-of-function mutants may be due to a change in the
recruitment of other histone deacetylases to these regions,
thereby altering the histone modification status at such
regions [15]. Moreover, recent data from large-scale, syn-
thetic genetic array (SGA) experiments reveal new, poten-
tial functions for Hmt1 in a cell [15-17].
Genome-wide location analysis is a powerful method that
allows one to comprehensively identify direct and indirect
protein-nucleic acid interactions across a specific genome
in vivo, by combining the method of chromatin immuno-
precipitation followed by hybridization to microarrays
reviewed in [18,19]. For yeast, this approach has been
utilized to study both DNA- and RNA-binding proteins
[20-23]. For example, genome-wide location analyses of
basal transcription factors have provided important infor-
mation on the marking of promoter regions within a
eukaryotic transcription circuit [24,25]. Additionally, the
ability to use antibodies directed against specific histone
modifications has enabled the creation of chromatin signa-
ture maps marking promoters that are either active or
repressed, as well as other genome elements such as enhan-
cers and transcribed regions reviewed in [26]. Thus, this
approach has helped answer important questions about
where in the genome a protein physically interacts and can
unravel critical details of gene regulation within a cell.
In this study, we have comprehensively mapped the
genome-wide occupancy for Hmt1 using NimbleGen
high-resolution tiling microarrays. Based on the profile of
genomic features bound by Hmt1, we found that Hmt1-
binding sites are located at a number of ORFs as well as
noncoding RNA (ncRNA) genes such as tRNA and
snoRNA genes. To probe the potential functional conse-
quence of Hmt1-occupancy at tRNA genes, we assayed
the steady-state levels of various tRNAs in Hmt1 loss-of-
function mutants and found their levels to be elevated
when compared to wild-type cells. This positive change in
the tRNA abundance in the Hmt1 loss-of-function
mutants is likely due to a changed transcriptional output
by RNA polymerase III (RNAPIII) rather than a change in
the tRNA maturation process. Lastly, coimmunoprecipita-
tion experiments show an association between Hmt1 andthe TFIIIB component Bdp1, which identifies a potential
molecular link by which Hmt1 is recruited to tRNA genes.
Together, these results provide a global view for Hmt1
function within the cell and reveal a novel role for Hmt1
in regulating tRNA biogenesis.
Results
Yeast genomic features bound by Hmt1
Hmt1 has been previously shown to be cotranscriptionally
recruited to genes [9] and Hmt1 loss-of-function mutants
display decreased levels of dimethylated arginine 3 of
histone H4 (H4R3) at silent chromatin regions [14].
Together, these observations demonstrate the significance
of Hmt1’s interaction with the genome in facilitating its
biological roles within a cell. While we have previously
carried out genome-wide location analysis for Hmt1 in the
past [9], that experiment used cDNA microarrays. Thus,
there remains a lack of knowledge with respect to other
genomic features that Hmt1 may interact with, such as
autonomous replicating sequences (ARSs) or non-coding
RNA (ncRNA) genes, which are not represented on the
cDNA microarray platforms. To address this gap in know-
ledge for Hmt1’s association with the genome, we have
comprehensively mapped the genome-wide occupancy of
Hmt1 using NimbleGen’s high-resolution yeast tiling
microarrays. These microarrays gave us the resolution and
coverage needed for fully assess Hmt1’s genome-wide occu-
pancy. After acquiring the data, ACME peak finding was
used to analyze individual microarray data sets. We then
used custom PERL scripts to integrate our biological tripli-
cate datasets and to identify Hmt1-binding sites. Using this
information, we were able to identify genomic features that
are enriched for Hmt1-binding sites in our data sets and
extracted peak sequences for analyses such as motif
discovery.
Overall, a total of 1012 Hmt1 binding sites (with a peak
size of 250 bp) were found to have passed the cutoff criteria
for statistical significance (see Additional file 1: Table S1).
Approximately 71% of these binding sites map to regions
within or proximal to an annotated ORF (within 125 bp of
the peak mid-point) (Figure 1A). However, this represents
only 10% of all ORFs within the genome (Figure 1B). Using
Gene Ontology enrichment analysis [27], we found that
ORFs bound by Hmt1 are enriched for genes involved in
translation (such as translational elongation, ribosomal
protein genes, cytosolic ribosome, etc) and in rRNA matu-
ration pathways (Table 1). Hmt1-binding sites also map to
a number of ncRNA genes, including tRNAs, snRNAs, and
snoRNAs, as well as ARSs (Figure 1A). The percentage of
total features within the yeast genome that are bound by
Hmt1 was calculated for each of the annotated genomic
element classes (Figure 1B). This analysis revealed that
Hmt1 binds to approximately 40% of all nuclear-encoded







































































Figure 1 Genome-wide binding profiles of Hmt1. A) Pie chart showing the fraction of Hmt1 binding sites that mapped to the indicated
genomic feature. B) The percentage of each genomic feature bound by Hmt1 as compared to the total number of that feature in the nuclear
genome. C) Directed ChIP validation of genes bound by Hmt1. ChIP signals were normalized to “No ORF”, which is an intergenic region on the
right arm of Chromosome IV [68]. TRA1, CDC2, and SPS2 were negative controls. The use of ACT1 was to demonstrate the enrichment of Hmt1
occupancy within specific regions of a gene body. Lastly, a number of tDNAs binding sites were confirmed.
Table 1 GO term analysis for gene functional groups enriched in Hmt1-binding sites
Adj. p-value GO attribute Description
<0.001 6414 translational elongation/protein synthesis elongation
<0.001 30533 triplet codon-amino acid adaptor activity/tRNA/transfer RNA
<0.001 16283 eukaryotic 48S initiation complex
<0.001 16072 rRNA metabolism
<0.001 16282 eukaryotic 43S preinitiation complex/eukaryotic 43S
<0.001 9451 RNA modification
<0.001 5843 cytosolic small ribosomal subunit/40S ribosomal subunit/cytosolic small ribosomal subunit
<0.001 30563 snRNA 2′ -O- ribose methylation guide activity
<0.001 17069 snRNA binding
<0.001 30561 RNA 2′ -O- ribose methylation guide activity
<0.001 30566 snRNA modification guide activity
<0.001 154 rRNA modification
<0.001 5842 cytosolic large ribosomal subunit/60S ribosomal subunit/cytosolic large ribosomal subunit
<0.001 30555 RNA modification guide activity
<0.001 30529 ribonucleoprotein complex/RNP
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http://www.biomedcentral.com/1471-2164/13/728To validate our high-resolution ChIP-chip data of
Hmt1, we used directed ChIP (ChIP-qPCR) to verify a
number of the identified binding sites. In each case, we
have identified Hmt1 enrichment at the regions tested
(Figure 1C). These features include specific regions
within a few ORFs and ncRNA genes. As a negative con-
trol, we measured Hmt1 enrichment at regions not found
in our Hmt1-bound dataset, such as TRA1 and SPS2
(Figure 1C). The results from our ChIP validation experi-









































































































































































Figure 2 Hmt1-binding sites are enriched at ORF genes. A) Average Hm
high- (“≥ 15 mRNA/hr”), medium- (“1-15 mRNA/hr”), and low- (“ ≤ 1 mRNA
calculations of promoters and genes for Hmt1-bound ORFs from Chromati
H4ac and H3K36me2. Representative ORFs bound-by Hmt1 were assayed f
cells.number of genomic features previously unknown, espe-
cially tRNA genes.
Characteristics of Hmt1-binding across ORFs
Previously, we have shown that Hmt1 is cotranscriptionally
recruited to the actively transcribing gene GAL10, with a
preference at the 5’-end to the middle of the GAL10 ORF
[9]. To examine the relationship between Hmt1 occupancy
and gene expression, we assigned ORF-encoding genes to













































































































































































t1 enrichment profiles for all ORFs bound (“ALL ORFs), ORFs with
/hr”) transcriptional frequencies. B) Histone enrichment/depletion
nDB. C) Directed ChIP to assess the role of Hmt1 on the levels of pan-
or the level of the specified histone modification in WT and hmt1-null
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genes that fall under each of the three different classes as
described previously [29] (Figure 2A, black lines in each
panel), then we plotted the average Hmt1-enrichment for
the set of ORFs that we classified as bound by our binding
site annotations (Figure 2A, red lines in each panel). For
highly transcribed genes (≥ 15 mRNAs/hr), such as those
involved in translation or ribosomal protein genes, there is
an obvious enrichment of Hmt1 from the 5’-end to the
middle of these highly transcribed genes (Figure 2A, upper
right panel, red line). This occupancy trend is similar to
what we had previously observed for Hmt1 on the GAL10
gene [9]. To our surprise, we observed a different trend for
Hmt1 occupancy across ORFs with medium and low tran-
scriptional rates (Figure 2A, lower right and lower left
panels). In general, Hmt1 occupancy is evenly distributed
across an ORF within these two transcriptional classes, with
the exception of a slightly higher occupancy at the 3’-end of
these ORFs. This is more apparent for the gene class with
medium transcriptional frequency (1 to 15 mRNAs/hr)
(Figure 2A, lower right panel, gray line).
Hmt1 methylates arginine 3 on histone H4 (H4R3)
in vitro [7] and mutants lacking Hmt1 or its catalytic acti-
vities display decreased levels of dimethylated H4R3 at
silent chromatin regions [14]. Since mutants lacking Hmt1
do not show a significant decrease in bulk dimethylated
H4R3 [7], it is possible that Hmt1’s effects on chromatin
may only occur within a specific chromosomal context,
such as those in the silent chromatin regions. Nevertheless,
PRMT1 (the mammalian homolog of Hmt1)-catalyzed
H4R3 methylation has been demonstrated as a key, initial
histone modification that is important for subsequent
histone modifications [30]. As such, we wanted to deter-
mine if Hmt1-bound ORFs displayed enrichment or deple-
tion for specific histone modifications. Using ChromatinDB,
we calculated the enrichment or depletion of 17 different
histone modifications and the five core histones for the
Hmt1-bound ORFs (Figure 2B) [31]. ChromatinDB calcu-
lates the enrichment/depletion in gene bodies as well as
promoter regions across the yeast genome [31]. Analysis of
the Hmt1-bound genes revealed that promoter regions were
enriched for H3K36me2 and pan-H3 acetylation, while
being depleted for H3/H4 occupancy (Figure 2B, promoter
panel). H3K4me2, pan-H3 acetylation, H3K56ac, and H2A.
Z occupancy are depleted, and H3K36me2 is enriched
across gene bodies (Figure 2B, ORF panel).
To assess whether Hmt1 regulates the modification of
histones based on our ChromatinDB analysis, we per-
formed directed ChIP using antibodies against pan-acetyl
H4 and H3K36me2 in wild-type and hmt1-null cells to
measure the levels of these modifications in ORF-gene
bodies since we find the majority of Hmt1 enrichment
here (Figure 2A). We tested the ORFs that were bound by
Hmt1 and representative of the histone modification trend(i.e. enriched/depleted for a specific modification) based
on the database analysis. With respect to pan-acetyl H4,
we do not observe any changes in the level between wild-
type and hmt1-null cells (Figure 2C, α-pan-H4ac panel).
When we compared the directed ChIP results for
H3K36me2 between wild-type and hmt1-null cells, we
found the majority of the ORFs we tested do not
change, but there was a slight increase in two loci –
BET4 and RPS13A (Figure 2C, α-H3K36me2 panel).
These results suggest that the absence (in the case of pan-
H4ac) or presence (in the case of H3K36me2) of these his-
tone modifications may regulate the recruitment of Hmt1
as opposed to Hmt1 regulating their levels in ORF gene
bodies.
Analysis of Hmt1-bound sequences for motif discovery
Because we were able to obtain detailed sequence-specific
information from the probes used in our high-resolution
microarray, we applied a number of motif finding algo-
rithms (AlignACE [32], MEME [33], WEEDER [34], and
MDScan [35]) to determine whether there exists a motif
within the Hmt1 binding sites. While our analyses revealed
enriched motifs, none of these appear to be of obvious
biological significance (data not shown). This was not
surprising to us, as Hmt1 has no reported DNA binding ac-
tivity and is likely to associate within the proximity of the
DNA via its interaction with DNA-binding proteins. This
type of indirect interaction likely will impede finding true
motif signals. However, we also took a reciprocal approach
in which we searched all of the Hmt1-binding sites for
known transcription factor sequence motifs using pre-
viously generated data [25,36,37]. Using the 250 bp window
for Hmt1-binding sites in our search and a negative con-
trol of 10,000 randomized yeast genome sequences of the
same size, we carried out an analysis for the enrichment of
known TF binding sites within our Hmt1-binding sites.
Our analyses did reveal a number of over-represented TF-
binding sites within the Hmt1-binding sites that passed
statistical significance cutoff (Additional files 2: Table S2).
A few of the most enriched TF-binding sites were for tran-
scription factors Cat8, Tbp1, Dal81, Ume6, and Mig1. Ex-
cept for Tbp1, which is the general, TATA-binding protein
that interacts with other factors to form the preinitiation
complex at promoters [38], the other four transcription
factors are all involved in specific metabolic pathways
[39-41] or life cycle stages (such as Ume6) [42]. Thus, it is
possible that Hmt1 functions together with these transcrip-
tion factors to help regulate the expression of genes involved
in these pathways.
Hmt1-binding is enriched at regions proximal to tRNA
genes
From our ChIP-chip data, we found that Hmt1-binding is
enriched across the 5’-regions that are proximal or within
AB
C
Figure 3 Hmt1-binding sites are enriched at tRNA genes. A) The
average Hmt1-enrichment pattern across all Hmt1-bound tDNA
features. B) Hmt1 loss-of-function mutants displayed increased tRNA
abundance. Bar graph showing RNA hybridization analysis results on
the relative abundance of mature tRNA tG(CCC) and tK(UUU) in the
Hmt1-null (Δhmt1) and Hmt1-catalytically inactive mutants (G68R).
Signals were normalized to the 5.8S rRNA (RNAPI transcript). C) Both
pre- and mature tRNA abundance is increased in Hmt1 loss-of-
function mutants. Bar graph showing RNA hybridization analysis
results on the relative abundance of pre- and mature tRNA tL(UAG)
in the Hmt1-null (Δhmt1) and Hmt1-catalytically inactive mutants
(G68R). Signals were normalized to the 5.8S rRNA (RNAPI transcript).
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(Figure 3A). Unlike the data from our Hmt1-bound ORF
analyses for genes with medium- and low-transcriptional
rates (Figure 2), we do not find any special enrichment for
Hmt1 near the 3’-end of the gene body (Figure 3A). Given
the preferred Hmt1 occupancy at an average tDNA gene,
it implicates a potential role for this enzyme in modulating
tRNA biogenesis, potentially either at the level of tran-
scription or via processing, as transcribed tRNAs undergo
many processing events such as base modification and
splicing during their maturation.
Interestingly, we found that the majority of Hmt1 occu-
pancy at tDNAs did not follow an all or none trend when
we examined the binding of Hmt1 to the entire set of
alleles for a specific tRNA gene species. For example, we
found Hmt1 occupancy at five of seven tDNAs encoding
tK(UUU). However, in some instances such as tDNAs that
encode tG(CCC), we did find Hmt1 occupancy at both of
the tDNA alleles. As a way to determine whether Hmt1-
binding may be correlated to the codon usage, we calcu-
lated the correlation coefficient for Hmt1-binding and
specific codon usage. However, such analysis did not re-
veal any credible candidates (data not shown), suggesting
that Hmt1-binding to these tDNA genes is likely a general
phenomenon.
Mutants lacking Hmt1 or its catalytic activity display
increased tRNA abundance
To determine if the observed enrichment of Hmt1-
binding around tRNA genes had any functional signifi-
cance, we used RNA hybridization assays to compare the
levels of steady-state tRNA abundances between wild-type
and Hmt1 loss-of-function mutants. We checked the
matured form of tRNA tG(CCC), which is encoded by two
tDNA alleles, both of which were bound by Hmt1 based
on our analysis. In both Hmt1 loss-of-function mutants,
there is an approximately two-fold increase in the levels of
mature tG(CCC) tRNA when compared to that of the
wild-type (Figure 3B, tG(CCC) panel). We next checked
another tRNA gene, tK(UUU), that had five out of seven
tDNA alleles bound by Hmt1. In this case, an increase in
tRNA abundance is still observed, but the magnitude of
the increase is not as significant as that of tG(CCC)
(Figure 3B).
During tRNA biogenesis, various processing steps must
take place in order to generate final, mature tRNAs. Hmt1
has been previously implicated in mRNP dynamics and
many of its substrates are mRNA processing factors. Thus,
it is possible that the change in the tRNA abundance
observed in the Hmt1 loss-of-function mutants may be due
to a role for Hmt1 in the tRNA processing steps. To test
this possibility, we used a previously published probe that
would hybridize equally to both the pre-processed form
and the mature form of tL(UAG), which had one out of
AB
Figure 4 Hmt1 physically associates with TFIIIB component
Bdp1. A) Affinity purification of Bdp1-TAP results in the co-
purification of Hmt1-myc, as shown by immunoblotting with α-myc
(for Hmt1) and α-Protein A (for Bdp1). B) Directed ChIP shows Hmt1
binding on tDNAs tR(CCU)J, tR(CCG)L, tL(UAG)J, tL(UAG)L2. ChIP
signals were normalized to “No ORF”, which is an intergenic region
on the right arm of Chromosome IV [68].
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an increase in the pre-tRNA in the Hmt1 loss-of-function
mutants, similar to that of the mature tRNA changes
(Figure 3C). Moreover, the ratio of pre-tRNA to total and
the ratio of mature tRNA to total were not changed in
these mutants. This comparison suggests that the increased
tRNA abundance observed for the Hmt1 loss-of-function
mutants is likely due to a change in the overall transcrip-
tional output of tRNA transcripts observed in these
mutants.
Hmt1 physically associates with TFIIIB component Bdp1
Knowing that Hmt1 is bound at tRNA genes and that
Hmt1 loss-of-function mutants display an increased tRNA
abundance, there exists a potential regulatory role for
Hmt1 in repressing RNAPIII transcription at tRNA genes.
Given that the average enrichment of Hmt1 is mostly at
the 5’-end and throughout the gene body, it is possible
that Hmt1 may exert its control on tRNA biogenesis
through some action on the components of the RNAPIII
machinery. Interestingly, a recent proteomic profiling
study for Hmt1 in our laboratory had identified the TFIIIB
component Bdp1 as a potential physical interactor of
Hmt1 (data not shown). Bdp1 is one of the three compo-
nents of TFIIIB [43] and has been implicated to function
as a scaffold for TFIIIB-DNA assembly [44]. To verify this
physical association between TAP-tagged Hmt1 and Bdp1,
we performed a co-immunoprecipitation with a reversed
bait and target. In this case, we purified TAP-tagged Bdp1
and the purified eluates were assayed for the presence
of myc-tagged Hmt1 by immunoblotting. Our immuno-
blotting data (Figure 4A) show that purification of
TAP-tagged Bdp1 results in co-purification of Hmt1. As a
negative control, we have carried out a parallel purification
using lysates from a yeast strain that lack TAP-tagged pro-
teins. Thus, we have confirmed the physical association
between TFIIIB component Bdp1 and that of Hmt1.
It is likely that the Hmt1 recruitment to tRNA genes
occurs via its physical association with Bdp1. While our
ChIP-chip data only show Hmt1-binding to approximately
40% of all tDNAs, the observation of Hmt1’s physical
association with Bdp1 suggests that Hmt1 is binding to
the majority of the tDNAs, if not all of them. This is based
on the fact that TFIIIB occupancy is found across all
tDNAs from a number of genome-wide location analyses
in S. cerevisiae [45-47]. Therefore, it is likely that our strin-
gent criteria for classifying what is considered an Hmt1-
bound locus excludes some true Hmt1-bound sites at
these tDNAs. To test this hypothesis, we used ChIP to
determine the association of Hmt1 at four different
tDNAs, which were not bound by Hmt1 based on our
ChIP-chip data. As shown in Figure 4B, however, there is
an enrichment of Hmt1 at all four tDNAs examined,
suggesting that indeed there may be some Hmt1-bindingsites that are excluded in our final ChIP-chip data set
because of high stringency. This also means that we are
highly confident of the Hmt1-binding sites determined
from our original analysis.
Discussion
In this study, we applied genome-wide location analysis
to uncover genomic features previously not known to
associate with Hmt1, the yeast homolog of human
PRMT1. To this end, we identified binding of Hmt1 to a
number of ncRNA genes such as tRNA and snoRNA
genes. Enrichment of Hmt1 binding at these genomic
features directly implicates a regulatory role for this pro-
tein in biological processes or pathways involving these
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cance of Hmt1 binding at the tRNA genes using RNA
hybridization analyses in assaying Hmt1 loss-of-function
mutants, which display an increase in the steady-state
levels of pre- and mature tRNA when compared to the
wild-type cells. This increase is likely attributed to a
change in the overall transcriptional output by RNAPIII,
as opposed to a defect in the maturation process of
tRNAs. The physical association between Hmt1 and
TFIIIB component Bdp1 provides a likely explanation
for Hmt1’s association at many of the tRNA genes in
our ChIP-chip data.
Hmt1 has previously been demonstrated to play a role
in the recruitment of mRNP components such as pre-
mRNA splicing factors [48] and mRNA export factors
[9]. Furthermore, it regulates transcriptional elongation
and termination via methylation of hnRNP and mRNA
export factor Npl3 [49]. Thus, it was not surprising for
us to find the majority of Hmt1 binding sites fall pro-
ximal to or within an ORF. GO-enrichment analysis
indicates Hmt1 binding to genes involved in translation,
suggesting a potential role for this enzyme in modulating
the expression of these genes. Transcriptional profiling
experiments carried out previously on both null and
catalytically-inactive mutants of Hmt1, however, show
no significant changes in the abundance of these tran-
scripts from the wild-type cells [9]. Based on these
observations, one possible explanation is that Hmt1’s
effects on these genes can only be seen under a specific
circumstance, such as a change in the environmental
condition or an exposure to certain stress agent. This
scenario would support the observed growth phenotype
for the Hmt1-null mutants as they display no distin-
guishable changes in their growth rate from wild-type
cells when grown in a rich media, such as YPD [6].
Transcription of HMT1 is repressed in response to heat
shock when compared to steady-state growth rate condi-
tions [50], further suggesting that Hmt1 is needed the
most only under a certain growth condition. It is interes-
ting to note that Hmt1 has different occupancy patterns
across genes with different transcriptional rates, as this
observation demonstrates a potential for different modes
of regulation during gene expression by Hmt1. There are
two functional implications of Hmt1’s enrichment across
the various transcriptional frequency gene classes – first,
the highly transcribed gene class contains many of the
ribosomal protein genes that encompass many intron-
containing genes and Hmt1 has been shown to be more
enriched at the 5’-end of these genes. Since Hmt1 affects
the co-transcriptional recruitment of pre-mRNA splicing
factors [10], Hmt1’s enrichment across this region may
reflect its role in regulating this process. Second, Hmt1’s
enrichment across all ORFs shows a “spike” at the 3’-end
of the genes, with this trend more pronounced in geneclasses with medium and low transcriptional frequencies.
This enrichment trend may reflect the association of Hmt1
with known substrates involved in 3’-end processing of a
transcript, such as Yra1, Hrp1, and Nab2. Thus, these
observations suggest that Hmt1 may methylate its substrate
during transcription rather than prior to.
Hmt1 methylates H4R3 in vitro [7] and loss-of-function
mutants of Hmt1 display decreased dimethylated H4R3
levels across silent chromatin regions [14], despite the
observation that bulk dimethylated H4R3 is unchanged in
hmt1 mutants [7]. Thus, Hmt1-catalyzed H4R3me2 in
S. cerevisiae is associated with gene silencing. H4R3
methylation by PRMT1 in vivo is required for many subse-
quent histone modifications in mammalian cells [30]. It
can be inferred then that Hmt1 may also play a role in
modulating the levels of other histone modifications. By
determining the enrichment or depletion of core histones
and other histone modifications for Hmt1-bound ORFs,
the data reveal that Hmt1 may coordinate regulation at
the promoter with H3-specific acetyltransferases such as
SAGA or NuaA3 and the Rpd3(S) complex, which is an
H3K36 methyl reader [51-53]. Furthermore, our ORF-
body analysis suggests that Hmt1 may coordinate the
action of COMPASS (responsible for H3K4 methylation),
Set2 (responsible for H3K36 methylation) as well as
KDACs [54-57]. Results from our directed ChIP experi-
ments, however, suggests that these histone modification
marks may regulate the recruitment of Hmt1 to ORF-
containing gene bodies instead, at least for pan-H4 acetyl-
ation and the majority of H4K36me2 tested. It is possible
that the loss of Hmt1 alone is not sufficient to alter these
histone modification states we have identified. Rather, it
may be the combination of Hmt1-deletion with the loss of
another regulator that effects a significant change in
histone modification levels as compared to any single loss-
of-function mutant.
Perhaps the most interesting hypothesis we obtained
from analyzing our ChIP-chip data is a role for Hmt1 in
the biogenesis of tRNAs. In eukaryotic cells, tRNAs are
classified on the basis of their anticodon, of which there
are 42 different tRNA species in the S. cerevisiae [58,59].
Furthermore, the actual number of different tRNA species
is greater in some cases because there can be species with
identical anticodons but sequence differences in the tRNA
body [60]. In S. cerevisiae, each tRNA species can be
encoded by several genomic copies (tDNAs), of which
there are a total of 274 nuclear-encoded tDNAs within the
genome [59]. Hmt1 binding is enriched at many of these
tDNA alleles and mutants lacking Hmt1 or its catalytic
activity display higher levels of the corresponding tRNA
abundance. This overall change is likely attributed to a
defect in the output rather than the processing during
tRNA biogenesis, as both pre- and mature tRNAs increase
in a similar fashion in the Hmt1 loss-of-function mutants.
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ted to a defect in tRNA processing in the Hmt1 mutants,
we would expect the ratio (pre- to mature tRNA) of sig-
nals obtained from our RNA hybridization analysis to
reflect such.
Transcription of tRNAs is accomplished by RNAPIII
and this process requires two gene-internal promoters,
boxA and boxB reviewed in [61,62]. During tRNA gene
transcription, these internal promoters are bound by the
hetero-heptameric complex TFIIIC. TFIIIC recruits the
hetero-trimeric TFIIIB (which consists of Bdp1, Brf1,
and TBP) to the upstream region of the tDNA. TFIIIB,
in turn, recruits RNAPIII to prompt transcriptional ini-
tiation. The physical interaction between Hmt1 and
Bdp1 provides a probable mechanism for how Hmt1
may be recruited to these tDNAs. Additionally, this
physical interaction gave insights into how Hmt1 may
affect the overall tRNA abundance through its ability to
regulate RNAPIII transcription of tRNA genes. While
the precise molecular mechanisms by which Hmt1
accomplishes this remains to be elucidated, our data
provide a valuable clue in that Hmt1 does so via its cata-
lytic activity, based on our data from the Hmt1 cataly-
tically inactive mutant. This points to a yet-to-be
discovered substrate of Hmt1 in which its methylation
may affect the transcription of tRNA genes by RNAPIII.
The biological significance of this transcriptional repres-
sion by Hmt1 could reflect a way for coordinating gene
expression between RNAPII and RNAPIII, given the
known role of Hmt1 in coordinating mRNP biogenesis
catalyzed by RNAPII. As it is advantageous for cells to
efficiently utilize its resources during growth (especially
in sub-optimal conditions), proper coordination would
be important for not wasting any valuable resources in
executing gene expression programs. Thus, it can be
inferred that Hmt1’s function in balancing these gene
expression programs may not be as critical when cells
are growing under optimal conditions with plenty of
resources, as supported by the observation that hmt1-
null cells do not display any obvious growth defect in
rich media. Further experiments are required to define
the specific molecular mechanisms used by Hmt1 in this
process as well as other roles Hmt1 may play in the
described occupancy relationship for genomic features
found within Hmt1 binding sites. In sum, our genome-
wide location analysis data do reveal multiple potentially
new roles for Hmt1 in the control of eukaryotic gene
expression in vivo, especially in the realm of ncRNA
biogenesis.
Conclusions
Our data on the comprehensive mapping of Hmt1 binding
sites across the yeast genome uncover many genomic fea-
tures previously not known to associate with Hmt1, therebyimplicating novel role of this enzyme in modulating
biological processes facilitated by these genomic features.
One such example we validated in this study is the tRNA
gene, for which Hmt1 occupancy is enriched. The func-
tional implication of Hmt1 binding on tRNA biogenesis is
supported by the observation that binding of Hmt1 at these
tRNA genes correlates with their abundance levels within a
cell. At the molecular level, our data suggest that Hmt1 is
recruited by Bdp1, a component of RNAPIII transcriptional
machinery, to the tRNA genes. Together, these results sug-
gest a potential role for Hmt1 in modulating tRNA
biogenesis via RNAPIII transcription. Overall, our study
demonstrates that knowledge of genome-wide locations
for a multi-functional protein such as Hmt1 has the
potential to lay the foundation for studies that reveal the
factors responsible for recruiting Hmt1 to a specific
genomic feature. Given the level of conservation between
Hmt1 and human PRMT1, it is likely that some of our
observations have implications for studies in higher
eukaryotes.
Methods
Yeast strains used in this study
All yeast Saccharomyces cerevisiae strains used in this
study are listed in Table 2 of the section. All strains were
grown at 30°C on YEPD medium (1% yeast extract, 2%
bactopeptone, 2% D-glucose, w/v) unless otherwise
stated
Hmt1 ChIP-chip experiment
The ChIP-chip procedure was performed as described
previously [9]. Briefly, formaldehyde was used to cross-
link myc-tagged Hmt1 and associated nucleic acids in
vegetatively growing yeast cells. Upon harvesting of
the crosslinked yeast cells, soluble chromatin was pre-
pared by sonication to generate chromatin fragments
on an average of 300bp. Following sonication, the
chromatin was subjected to immunoprecipitation
using 9E11 anti-myc antibody (ThermoFisher) to en-
rich for Hmt1-associated DNA. After reversal of the
crosslinks, the enriched DNA was amplified linearly by
ligation-mediated PCR. As a control, a sample was
prepared from total DNA (without undergoing immu-
noprecipitation). The resulting, enriched DNA samples
were sent to NimbleGen for hybridization to high-
resolution S. cerevisiae tiling arrays (385K arrays),
followed by the scanning and pre-processing of the
array data. All the microarray data were deposited in
NCBI's GEO database, Accession: GSE40505
For data analysis, the “Algorithm for Capturing Micro-
array Enrichment” (ACME) [63] was used to determine the
sequence regions that were bound by epitope-tagged Hmt1
on the chromosome. ACME, which does not assume that
log2 ratio data are Gaussian-distributed like other
Table 2 Yeast strains used
Strain # Genotype Ref
MYY65 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ HMT1::9MYC::TRP [9]
BY4741 his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0 [70]
MYY649 his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0 Δhmt1::KANMX6 hmt1-G68R::LEU2 This Work
MYY432 his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0 Δhmt1::KANMX6 This Work
MYY1200 his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0 BDP1::TAP::HIS3 HMT1::9MYC::NATR This Work
MYY1097 his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0 HMT1::9myc::NATR This Work
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enriched for signal in the positive direction (“one-tailed”)
and (2) that the real signal will be represented by multiple
probes that are genomically located close to one another
(“neighbor effect”). Despite its simplicity, ACME has been
proven to be quite robust at detecting true signal from
noise [64]. For our analysis, the raw array data was norma-
lized using bi-weight mean by NimbleScan Version 2.1
software (NimbleGen Systems).
To identify potential sites of enrichment, multiple sliding
windows of 600–, 800– and 1,000–bp were separately
employed to move stepwise along the tiled region, cente-
ring at every probe. Hybridization signals of probes within
each window were tested by χ2 analysis to determine if the
window contains a higher than expected number of probe
signals above the defined threshold. The resulting p-value
that is associated with each averaged data point was used
for the selection of significant regions. To minimize false
positives, we also employed a two-state hidden Markov
model in an independent parallel analysis of the data set
[65], in which two distributions were constructed to
characterize binding and non-binding probe intensities, to
determine regions of significance. The common significant
regions from the above two methods were considered to be
true signals. The three biological replicate sets of Hmt1
binding site data generated were then coalesced by asses-
sing the binding-site midpoint distances and merging peaks
from at least two datasets that were less than 125 bp apart.
Peaks were then either extended or truncated to 250 bp
(midpoint +/- 125 bp) for uniformity.
Bioinformatics analysis of Hmt1 binding sites
Annotations were done using PERL scripts and a dump of
the SGD genome database feature file (downloaded on 09/
2010). Average feature plots were generated as previously
described [29]. Briefly, ORF sets were partitioned into
50 bins and the probes were summed and averaged for
each bin. To minimize sampling errors, the average
bin size for a class of ORFs was used to create bins in the
upstream and downstream regions, which were fixed at
250 bp. For motif searches, Hmt1-binding sequences were
first masked (A.F.A. Smit, R. Hubley & P. Green, unpub-
lished data. Current Version: open-3.3.0) and then analyzedusing MEME [33], AlignACE [32], Weeder [34], and
MDScan [35] with their default settings.
Histone modification enrichment/depletion analysis was
carried out at the ChromatinDB website (http://www.bio-
informatics2.wsu.edu/cgibin/ChromatinDB/cgi/visualize_-
select.pl) [31]. The input list of Hmt1-bound ORFs was
used for nucleosome occupancy-normalized histone modi-
fications, with a p-value cutoff of 0.001, and Bonferroni
multiple hypothesis test correction [31].
To search whether the identified Hmt1 binding sites are
enriched for other transcription factor (TF) binding sites,
we preformed the following analysis: A size of 250 bp is
assigned for each peak and used to determine which TF
binds the peak. The CLOVER program was used with 184
fungi position weight matrixes (PWMs) from public do-
main information on TFs [66] to predict TF binding sites.
Parameters of CLOVER [67] were set for 1000 randomiza-
tions and a p-value threshold of 0.05 using background
sequences of 10,000 random DNA fragments of the same
size generated from yeast chromosomes 1, 3, 5, 7, and 9
(2000 fragments from each chromosome).
Chromatin immunoprecipitation (ChIP)
ChIP procedures were performed as described previously
[68] with at least duplicate biological samples (Hmt1-myc;
n=2, pan-acetyl-H4 and H3K36me2; n=3). For each bio-
logical replicate, qPCR was performed in three technical
replicates. For qPCR, 2 μl of DNA sample (input or IP)
was used in 20 μl reactions with 250-500nM final concen-
tration of each primer and Bio-Rad Sso Advanced SYBR
Green Supermix or Invitrogen Power SYBR Green PCR
Master Mix. Table 3 shows the primers used in all qPCR
experiments in this study. For each immunoprecipitation,
10 μl of monoclonal α-myc (9E11, Thermo-Fisher), or 5 μl
of α-H3K36me2 (EMD Millipore cat#07-369), or 5 μl of
α-pan-acetyl-H4 (Upstate Biotechnology, cat#06-598) was
pre-coupled to 40 μl of Protein-A sepharose beads.
RNA hybridization analysis
Total RNA was prepared from yeast strains (Table 2)
grown to early log phase (OD600=0.2 to 0.3), using the hot
phenol method as previously described [69]. For RNA
hybridization analysis, 20 μg of total RNA was resolved on
Table 3 Oligonucleotides used in this study
NAME Sequence (5′ –> 3′) Reference
5′ –PMA1(sense) CGACGACGAAGACAGT GATAACG This study
5′ –PMA1(anti-sense) ATTGAATTGGACCGACGAAAAACAT AAC This study
3′ –PMA1 (sense) AAA CAA CCA GCT TCG GTG TGT GTG This study
3′ –PMA1 (anti-sense) TAG GAG CCA ACA AGA ATA AGC CGC This study
ILV5 (sense) ATT GGG TAC CAG TCC AAA GCA CCT This study
ILV5 (anti-sense) ACC GTC GAA GAA GCT ACC CAA TCT This study
RPS25A (sense) TGG GTA GCT AGA TCT GTG CTA TGG This study
RPS25A (anti-sense) GAA ATA GTG ACT GGC CAA TCC AGG This study
GAL1 (sense) TGCTAGATCGCCTGGTAGAG [72]
GAL1 (anti-sense) GCAAACCTTTCCGGTGCAAG [72]
MND1 (sense) CCATCATGGTACACAGGACTGAACA This study
MND1 (anti-sense) GGAGTGATACTGTCTGTCTCTTTGGC This study
BET4 (sense) CGACAGCAAGTTCAGTTTGCCACA This study
BET4 (anti-sense) AGCGAGTTTGGCTTCTGAGTTGGA This study
SEC31 (sense) CCAAATGATATCGCCCAGAGGAATG This study
SEC31 (anti-sense) CCGGCAGCCAAGTACAAAGTCAAA This study
RPS13A (sense) CAGAAAGCACTGGCAAGAACGTGT This study
RPS13A (anti-sense) TCTGCCAGCTCTGACCTTTCTGTT This study
RPS14A (sense) TGGTAAGGAAACCATCGCCAGAGT This study
RPS14A (anti-sense) TAACGTGAACGGCAGTGATACCGA This study
YLL011W (sense) AGCCAGTTTCCGATCTATCATGGG This study
YLL011W (anti-sense) GGCCTCCATTGGATTCCAGCAAAT This study
snR37 (sense) TGGAGTGTGAGTGATGAGGAGCTT This study
snR37 (anti-sense) GGAGTAGTCAAAGTTCATTCAGCTATGGG This study
snR42 (sense) CTGTTGGTGCTGAGGTAATCCATC This study
snR42 (anti-sense) ACCTCAGGTCATCACCATTTCATGGG This study
ACT1 5′ end (sense) GTCCCAATTGCTCGAGAGATTTCTC This study
ACT1 5′ end(anti-sense) CATGATACCTTGGTGTCTTGGTC This study
ACT1 3′ end(sense) TCGAACAAGAAATGCAAACCG This study
ACT1 3′ end(anti-sense) GGCAGATTCCAAACCCAAAAC This study
CDC2 (sense) CCTGCCTTTAAGGCTTATGGA This study
CDC2 (anti-sense) CCACGAATAGGCTCAATAACA This study
TRA1 (sense) CCAATTTTTGATAAGCCACCCTGA This study
TRA1 (anti-sense) CGTAATTTCTAAGGTCTTGTTCTCCCA This study
SPS2 (sense) ACTGTCCCGTCATTGATGCGTCTC [73]
SPS2 (anti-sense) GGGATCGTTGCATTAGTGTTAACC [73]
No ORF (sense) GAAAAAGTGGGATTCTGCCTGTGG [68]
No ORF (anti-sense) GTTTGCCACAGCGACAGAAGTATAACC [68]
tG (CCC) D (sense) AAATGCGGAAGCCGGGAATCGAA This study
tG (CCC) D (anti-sense) GGTATTTCTTTGCGCGGTTACGGT This study
tL (UAG) L1 (sense) GGT TAAACCCAC CTAAATCTGACGCC This study
tL (UAG) L1 (anti-sense) TGGCTAACCCAATGGCTTGT This study
tW (CCA) P (sense) AAGCTGAGTGTCCGCTGTGATGAT This study
tW (CCA) P (anti-sense) TTGCAATCGAAGGGTTGCAGGTTC This study
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Table 3 Oligonucleotides used in this study (Continued)
tK (UUU )D (sense) TGTTGGAACGGTAAAGACCAGTGC This study
tK (UUU) D (anti-sense) AAAGCCGAACGCTCTACCAACTGA This study
tG (CCC) probe ATGCTTGGGAAGCATAAATTCTA This study
tL (UAG) probe AAGATATCAGAGCCTAAATCTGACG [71]
pre-t L(UAG) probe GATATCAGAGATTTTAGAGGTTAAATCCACCT [71]
5.8S probe GCGTTGTTCATCGATGC This study
tK (UUU) probe TGACATTTCGGTTAAAAGCCGAACGCTCTACCAAC [71]
tR (CCG) L (sense) AAGTACGACATCAAAGTCGCCGAG This study
tR (CCG) L (anti-sense) TGCTAACCATTGCACTAGAGGAGC This study
snR128 (sense) ACAGTATACGATCACTCAGACATCC This study
snR128 (anti-sense) CACGGTGATGAAAGACTGGTTCCT This study
tR (CCU) L (sense) CCACATTCTCTACAATATTGATTTCCATCG This study
tR (CCU) L (anti-sense) CCATTACGCCAACGGAACCAACTT This study
tL (UAG) L2 (sense) ATCGACAGCTTCACGTGCCATTTG This study
tL (UAG) L2 (anti-sense) CTGATATCTTCGGATGCAAGGGTTCG This study
tL (UAG) J (sense) GGTTAAACCCACCTAAATCTGACGCC This study
tL (UAG) J (anti-sense) TGGCTAACCCAATGGCTTGT This study
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HybondN+ Nylon membranes (GE Healthcare) using
Bio-Rad semi-dry transfer (150 mA for 1hr). The mem-
branes were then UV-crosslinked with a Stratalinker using
the Optimal Crosslink setting. Membranes were hybri-
dized in 3X SSC, 1X Denhardt’s, 0.5% SDS, and 100
μg/mL sheared salmon sperm DNA overnight at 37°C
with 32P-end labeled oligonucleotide probes (see Table 3
for sequences). After hybridization, membranes were
rinsed once and then washed twice for 20 mins with 50 ml
of 2X SSC/0.1% SDS buffer at 37°C. The membranes were
exposed to PhosphorStorage screens, scanned with a
PhosphorImager (Molecular Dynamics) and quantified
using the ImageQuant software.Coimmunoprecipitation study between Hmt1 and Bdp1
Preparation of yeast cell lysates for co-immunopreci-
pitations between Hmt1-myc and Bdp1-TAP was car-
ried out as described previously [48]. Bdp1-TAP was
purified by incubating prepared yeast cell lysates with
40 μL IgG sepharose beads (GE-Amersham) for 2
hours at 4°C, followed by three washes with IPP150
buffer. Bound protein was eluted in 300 μL Elution
Buffer (0.5 M Acetic Acid pH 3.5), precipitated with
trichloroacetic acid (TCA) overnight at -20°C, reco-
vered, and resolved on a NuPAGE 4-12% Bis-Tris
gradient gel (Life Technologies). The immunoblot was
probed with an anti-myc antibody (Santa Cruz A-14),
stripped, and re-probed with an of the immunoblot
α-Protein A antibody (Sigma, cat#P3775).Additional files
Additional file 1: Table S1. Hmt1 binding site coordinates trimmed to
250 bp. The file is in gff format, the columns are listed below: Column 1:
Chromosome. Column 2: Source. Column 3: feature. Column 4: Start
Coordinate. Column 5: Stop Coordinate. Column 6: Score. Column 7:
Strand. Column 8: Reading Frame. Column 9: Attributes
Additional file 2: Table S2. TF motif search. Results from transcription
factor motif search. Transcription factors are listed on left, followed by
number of Hmt1 peaks found to contain the TF’s motif. Followed by
three different methods of background motif estimation. 1) Sequence
shuffle of Hmt1 peaks, 2) S. cerevisiae promoter sequences
(-500bp to +100bp of every ORF) and 3) 3’-UTR sequences for each ORF.
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